Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thornberry Nancy −$262K Director sold 37% of stake
  2. Schuth Alexander O. −$65K COFO and Secretary sold <1% of stake
  3. Chin Peter Scott −$37K Chief Medical Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2018-02-26 Krognes Steve E. CFO and Treasurer Grant or award · Stock Option (right to buy) +180,000 180,000
2018-02-26 Schuth Alexander O. COO and Secretary Grant or award · Stock Option (right to buy) +180,000 180,000
2018-02-26 Watts Ryan J. President and CEO Grant or award · Stock Option (right to buy) +300,000 300,000
2017-12-13 Watts Ryan J. President and CEO Grant or award +5 $20.47 $102 12,505
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion +14,499,999 14,812,499
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion +2,500,000 17,312,499
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion +1,875,000 19,187,499
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion +743,599 743,599
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion +128,200 871,799
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion +240,000 1,111,799
2017-12-12 BRATTON DOUGLAS K 10% owner Purchase +275,000 $18.00 $5.0M 19,462,499
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion · Series A-1 Convertible Preferred Stock −14,499,999 0
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion · Series A-2 Convertible Preferred Stock −2,500,000 0
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion · Series B-1 Convertible Preferred Stock −1,875,000 0
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion · Series A-1 Convertible Preferred Stock −743,599 0
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion · Series A-2 Convertible Preferred Stock −128,200 0
2017-12-12 BRATTON DOUGLAS K 10% owner Conversion · Series B-1 Convertible Preferred Stock −240,000 0
2017-12-12 FIL Ltd See Remark 1 Conversion +1,397,326 1,814,208
2017-12-12 FIL Ltd See Remark 1 Conversion +28,750 1,842,958
2017-12-12 FIL Ltd See Remark 1 Conversion +71,875 1,914,833

Page 48 of 53 · 1,053 trades